AANMS Theranostics Course Presentations 2022
City 24 – 25 Month 2022
1. Panel Discussion Day 1 Session 1
2. Panel Discussion Day 1 Session 2
3. Radiochemistry for the theranostics specialist Dr Mo Haskali
4. Surgical management of NETs – overview Dr Benjamin Loveday
5. Theranostics in Australia the local perspective AProf Sze Ting Lee
6. Welcome AProf David Pattison
7. Lutetium therapy practicalities Mr Mark Scalzo
8. NETS – peptide receptor radionuclide therapy AProf Gabby Cehic
9. NETs therapy case discussions – patient selection, complications & response assessment
10. Panel Discussion Day 1 Session 4
11. Prostate Cancer – clinical overview & early treatment options Prof Declan Murphy
12. Prostate cancer – molecular imaging overview, pearls & pitfalls Prof Louise Emmett
13. Prostate Cancer – treatment of metastatic disease AProf Arun Azad
14. LuPSMA case discussions – patient selection, complications & response assessment
15. Thyroid Cancer – clinical overview & treatment landscape AProf Don Macleod
16. Thyroid cancer – molecular imaging overview AProf Sze Ting Lee
17. Thyroid cancer – RAI therapy pearls, pitfalls & new developments AProf David Pattison
18. Thyroid cancer case discussions – patient selection, complications & response assessment
19. ARTNET trials in Theranostics AProf Roslyn Francis
20. Concluding remarks AProf David Pattison
21. Future of Theranostics trials, alpha & combination therapies Prof Ken Herrmann & Prof Louise Emmett
22. Global perspective on theranostics Prof Andrew Scott
23. Paediatric radionuclide therapy Dr Kevin London
24. Rhenium-188 for non-melanoma skin cancer Dr Geoff Schembri
25. Selective Internal Radiation Therapy Dr Yung Kao